🤖 AI Summary
Existing biological network evaluation metrics often neglect the qualitative nature of regulatory relationships (e.g., activation vs. inhibition), rendering them incapable of distinguishing networks that are structurally accurate but functionally erroneous. To address this, we propose the signed Structural Intervention Distance (sSID) and its weighted variant, the first metrics to integrate gene regulatory sign information with net intervention effects within the SID framework—enabling joint assessment of structural and functional consistency. Extensive validation on both synthetic and real transcriptomic datasets demonstrates that sSID identifies functionally superior networks undetectable by conventional metrics. Moreover, networks selected using sSID significantly improve clinical phenotype classification performance. By explicitly encoding biological directionality and causal semantics, sSID enhances both interpretability and practical utility in network evaluation. This work establishes a new biologically grounded benchmark for inferring and assessing regulatory networks.
📝 Abstract
Estimating causal networks from biological data is a critical step in systems biology. When evaluating the inferred network, assessing the networks based on their intervention effects is particularly important for downstream probabilistic reasoning and the identification of potential drug targets. In the context of gene regulatory network inference, biological databases are often used as reference sources. These databases typically describe relationships in a qualitative rather than quantitative manner. However, few evaluation metrics have been developed that take this qualitative nature into account. To address this, we developed a metric, the sign-augmented Structural Intervention Distance (sSID), and a weighted sSID that incorporates the net effects of the intervention. Through simulations and analyses of real transcriptomic datasets, we found that our proposed metrics could identify a different algorithm as optimal compared to conventional metrics, and the network selected by sSID had a superior performance in the classification task of clinical covariates using transcriptomic data. This suggests that sSID can distinguish networks that are structurally correct but functionally incorrect, highlighting its potential as a more biologically meaningful and practical evaluation metric.